Client News

SciSparc (Nasdaq: SPRC) Granted Another Patent, Strengthening its Core Technology in Canada

TEL AVIV, Israel, March 18, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, today announced that it has been granted a patent for its core-technology, the combination of cannabinoids and […]

BYND Cannasoft Enterprises Inc. (Nasdaq:BCAN) Announces Closing of $7.0 Million Underwritten Public Offering

Vancouver, British Columbia –News Direct– BYND Cannasoft Enterprises ASHKELON, Israel and VANCOUVER, British Columbia – TheNewswire – March 14, 2024 – BYND Cannasoft Enterprises Inc. (Nasdaq:BCAN) (CSE:BYND) (“BYND Cannasoft” or the “Company”) an Israeli-based integrated software and cannabis company, today announced the closing of a firm commitment underwritten public offering with gross proceeds to the […]

American Rebel (NASDAQ: AREB) Announces $19.9+ Million Public 8.53% Preferred Offering

Nashville, TN, March 15, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), is pleased to announce the launch of a Regulation A+, equity financing of up to $19,999,995 of 8.53% Series C Redeemable Convertible Preferred Stock (the “Public Offering”). This Public Offering is a watershed event for the Company and allows […]

CN Energy Group (Nasdaq: CNEY) Receives Re-order from Water Purification Customer for its Activated Carbon

LISHUI, China, March 15, 2024 /PRNewswire/ — CN Energy Group. Inc. (Nasdaq: CNEY) (the “Company” or “CN Energy Group”), a high-tech enterprise specializing in cogeneration of high-quality wood-activated carbon and clean energy, today announced that its wholly owned subsidiary, Zhejiang CN Energy New Materials Co., Ltd., has received a re-order to supply its high-quality wood-based activated carbon to an […]

SciSparc (Nasdaq: SPRC) Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial

First patient has been dosed in the randomized, controlled, double blind clinical trial for Autism Spectrum Disorder in pediatric patients TEL AVIV, Israel, March 14, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous […]

1847 Holdings’ (NYSE American:EFSH) ICU Eyewear Subsidiary Diversifies Manufacturing to Reduce Production Costs and Fortify Supply Chain

NEW YORK, NY / ACCESSWIRE / March 13, 2024 / 1847 Holdings LLC (“1847” or the “Company”) (NYSE American:EFSH), a unique holding company that combines the attractive attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly traded company, today announced that its subsidiary, ICU Eyewear Holdings Inc. (“ICU”), has significantly […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.